Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-046561
Filing Date
2021-07-13
Accepted
2021-07-13 17:05:27
Documents
1
Period of Report
2021-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3831
  Complete submission text file 0001209191-21-046561.txt   5221
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL NEUROPHARMA INC (Issuer) CIK: 0001445499 (see all company filings)

EIN.: 263058238 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMPEL NEUROPHARMA, INC. 201 ELLIOTT AVE. W, ST. 260 SEATTLE WA 98119
Business Address
Allison David D. (Reporting) CIK: 0001853903 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40353 | Film No.: 211088545